Prediction model for treatment response of primary membranous nephropathy with nephrotic syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prediction model for treatment response of primary membranous nephropathy with nephrotic syndrome

Published:2024-05-06 Issue:8 Volume:28 Page:740-750
ISSN:1342-1751
Container-title:Clinical and Experimental Nephrology
language:en
Short-container-title:Clin Exp Nephrol

Author:

Li Min,Lai Xiaoying,Liu Jun,Yu Yahuan,Li Xianyi,Liu Xuemei

Funder

Project of Science and Technology of Qingdao People’s Livelihood

Qingdao Key Health Discipline Development Fund

Qingdao Key Clinical Specialty Elite Discipline

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10157-024-02470-1.pdf

Reference36 articles.

1. Yokoyama H, Yamamoto R, Imai E, Maruyama S, Sugiyama H, Nitta K, et al. Better remission rates in elderly Japanese patients with primary membranous nephropathy in nationwide real-world practice: the Japan Nephrotic Syndrome Cohort Study (JNSCS). Clin Exp Nephrol. 2020;24(10):893–909. https://doi.org/10.1007/s10157-020-01913-9.

2. Thompson A, Cattran DC, Blank M, Nachman PH. Complete and partial remission as surrogate end points in membranous nephropathy. J Am Soc Nephrol. 2015;26(12):2930–7. https://doi.org/10.1681/asn.2015010091.

3. Hofstra JM, Fervenza FC, Wetzels JF. Treatment of idiopathic membranous nephropathy. Nat Rev Nephrol. 2013;9(8):443–58. https://doi.org/10.1038/nrneph.2013.125.

4. Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361(1):11–21. https://doi.org/10.1056/NEJMoa0810457.

5. Stefan G, Stancu S, Zugravu A, Popa O, Zubidat D, Petre N, et al. Negative anti-phospholipase A2 receptor antibody status at three months predicts remission in primary membranous nephropathy. Ren Fail. 2022;44(1):258–68. https://doi.org/10.1080/0886022x.2022.2033265.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3